This may be because of the accumulation of ubiquitinated proteins and three proteasome target proteins, Bax, p27 and IκBα, in androgen receptor (AR)-negative PC-3 prostate cancer cells, which supports the conclusion that proteasome is inhibited by pristimerin [120]. Here, AR is linked to prostate cancer.